These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29129650)

  • 1. Forecasting the future burden of opioids for osteoarthritis.
    Ackerman IN; Zomer E; Gilmartin-Thomas JF; Liew D
    Osteoarthritis Cartilage; 2018 Mar; 26(3):350-355. PubMed ID: 29129650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain.
    Rejas-Gutierrez J; Sicras-Mainar A; Darbà J
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211010599. PubMed ID: 33995603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
    Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
    Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected Burden of Osteoarthritis and Rheumatoid Arthritis in Australia: A Population-Level Analysis.
    Ackerman IN; Pratt C; Gorelik A; Liew D
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):877-883. PubMed ID: 28898565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.
    Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R
    Intern Med J; 2016 Aug; 46(8):955-63. PubMed ID: 26602489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid analgesic use in Australia and The Netherlands: a cross-country comparison.
    Wagemaakers FN; Hollingworth SA; Kreijkamp-Kaspers S; Tee EHL; Leendertse AJ; van Driel ML
    Int J Clin Pharm; 2017 Aug; 39(4):874-880. PubMed ID: 28608330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030.
    Ackerman IN; Bohensky MA; Zomer E; Tacey M; Gorelik A; Brand CA; de Steiger R
    BMC Musculoskelet Disord; 2019 Feb; 20(1):90. PubMed ID: 30797228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation.
    Islam MM; McRae IS; Mazumdar S; Simpson P; Wollersheim D; Fatema K; Butler T
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):30. PubMed ID: 29914572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients.
    Yenikomshian MA; White AG; Carson ME; Garrison LP; Oderda GM; Biskupiak JE; Hlavacek PR; Roland CL
    J Opioid Manag; 2017; 13(5):291-301. PubMed ID: 29199395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years.
    Adewumi AD; Maravilla JC; Alati R; Hollingworth SA; Hu X; Loveday B; Connor JP
    Int J Clin Pharm; 2021 Apr; 43(2):328-339. PubMed ID: 32964404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate opioid dispensing in patients with knee and hip osteoarthritis: a population-based cohort study.
    Thorlund JB; Turkiewicz A; Prieto-Alhambra D; Englund M
    Osteoarthritis Cartilage; 2020 Feb; 28(2):146-153. PubMed ID: 31669311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
    Kumar VM; Agboola F; Synnott PG; Segel C; Webb M; Ollendorf DA; Banken R; Chapman RH
    Value Health; 2019 Apr; 22(4):416-422. PubMed ID: 30975392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse selection? A multi-dimensional profile of people dispensed opioid analgesics for persistent non-cancer pain.
    Rogers KD; Kemp A; McLachlan AJ; Blyth F
    PLoS One; 2013; 8(12):e80095. PubMed ID: 24312456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia.
    Degenhardt L; Blanch B; Gisev N; Larance B; Pearson S
    BMJ Open; 2015 Jan; 5(1):e007030. PubMed ID: 25631315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
    Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
    Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the patterns of prescription opioid use, costs and related harms in Australia.
    Blanch B; Pearson SA; Haber PS
    Br J Clin Pharmacol; 2014 Nov; 78(5):1159-66. PubMed ID: 24962372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of chronic pain for patients with osteoarthritis in Germany: a retrospective cohort study of claims data.
    Schild M; Müller U; von Schenck U; Prieur S; Miller R
    BMC Musculoskelet Disord; 2021 Mar; 22(1):317. PubMed ID: 33789636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription opioid utilization patterns, and associated outcomes, among privately insured patients prescribed opioids to manage pain associated with osteoarthritis.
    Schepman P; Rice JB; Beck CG; White A; Robinson RL; Thakkar S; Fernan C; Emir B; Silverman S
    Curr Med Res Opin; 2023 Aug; 39(8):1147-1156. PubMed ID: 37435803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid therapy in the treatment of chronic pain conditions in Germany.
    Werber A; Marschall U; L'hoest H; Hauser W; Moradi B; Schiltenwolf M
    Pain Physician; 2015; 18(3):E323-31. PubMed ID: 26000679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of pain interference and opioid use with healthcare utilization and costs, and wage loss among adults with osteoarthritis in the United States.
    Zhao X; Shah D; Gandhi K; Wei W; Dwibedi N; Webster L; Sambamoorthi U
    J Med Econ; 2019 Nov; 22(11):1192-1201. PubMed ID: 31433685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.